Corvus Pharmaceuticals
CRVS
#7809
Rank
โ‚ฌ0.22 B
Marketcap
3,24ย โ‚ฌ
Share price
4.69%
Change (1 day)
126.75%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -โ‚ฌ56.9 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚ฌ23.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ54.79 Million130.47%
2023 -โ‚ฌ23.78 Million-34.57%
2022 -โ‚ฌ36.33 Million-4.47%
2021 -โ‚ฌ38.04 Million621.28%
2020 -โ‚ฌ5.28 Million-87.16%
2019 -โ‚ฌ41.05 Million-0.57%
2018 -โ‚ฌ41.29 Million-15.67%
2017 -โ‚ฌ48.96 Million53.03%
2016 -โ‚ฌ32 Million16.08%
2015 -โ‚ฌ27.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.13 Billion 129.39%๐Ÿ‡บ๐Ÿ‡ธ USA